1 year return (CAGR)
4.93%
Jubilant Pharmova Limited Exchange (NSE, INR)
JUBLPHARMA.NSE
-
+21.20 (+2.24%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
39.79%
5 year return (CAGR)
3.31%
10 year return (CAGR)
9.11%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
153.21B
Price/Sales
2.01
Ent value
216.47B
Price/Book
2.33
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
32.07
PEG
-
Forward P/E
20.08
EPS growth
-1.30%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 954.90 |
| Daily high | 973.60 |
| Daily low | 952.10 |
| Daily Volume | 54K |
| 1y analyst estimate | 1394.00 |
| Beta | 0.67 |
| EPS (TTM) | 30.06 |
| Dividend per share | 0.00 |
| Ex-div date | 25 Jul 2025 |
| Next earnings date | 22 May 2026 |
Downside potential
Loading...
Downside potential data
| JUBLPHARMA.NSE | S&P500 | |
| Current price drop from All-time high | -23.72% | -0.89% |
| Highest price drop | -85.54% | -56.47% |
| Date of highest drop | 16 Apr 2001 | 9 Mar 2009 |
| Avg drop from high | -41.37% | -10.67% |
| Avg time to new high | 56 days | 12 days |
| Max time to new high | 2024 days | 1805 days |
News
No items found